|
2008 Triple Negative Breast Cancer Symposium
Agenda
|
||
| TOPIC | PRESENTER/FACILITATOR | TIME |
| Welcome | Allison Axenrod, Hayley Dinerman | 8:30 8:35 |
| Biology of Triple Negative Breast Cancer | ||
| Umbrella of Triple Negative Disease | Charles M. Perou | 8:35 8:50 |
| Update on BRCA1 Pathway Regulation and Targetability in Sporadic Basal-Like Tumors | Dan Silver | 8:50 9:05 |
| Patterns of Metastatic Spread | Eric Winer | 9:05 9:15 |
| Discussion | 9:15 9:35 | |
|
Breast Tumor Size, Lymph Node Status And Survival In Triple Negative Breast Cancer: Not So Simple
Update on Prognostic and Therapeutic Implications Of BRCA-Associated Tumors |
William D. Foulkes | 9:35 9:50 |
| Discussion | 9:50 10:05 | |
| Identification and Diagnosis Should There Be a Unified Approach? | Andrea Richardson | 10:05 10:20 |
| Discussion | 10:20 10:40 | |
| PARP Inhibition as a Therapeutic Strategy - Basic Science and Clinical Trials | Andrew Tutt | 10:40 11:00 |
| Discussion | 11:00 11:20 | |
| Racial Disparities in Triple Negative Disease Implications for Screening and Treatment | Lisa Newman | 11:20 11:40 |
| Discussion | 11:40 12:00 | |
| LUNCH BREAK | 12:00 12:40 | |
| EGFR Debate | ||
| EGFR Is A Relevant Target | Lisa Carey | 12:40 12:50 |
| EGFR Is Not a Relevant Target in Triple Negative | Lyndsay Harris | 12:50 1:00 |
| Discussion | 1:00 1:20 | |
| Platinum Agents Debate | ||
| Platinum Agents Are Relevant for Triple Negative | Steve Isakoff | 1:20 1:30 |
| Platinum Agents Are Not Significant for Triple Negative | Cliff Hudis | 1:30 1:40 |
| Discussion | 1:40 2:00 | |
| Facilitated Discussion Appropriate Targets and Most Promising Avenues | George Sledge/Eric Winer | 2:00 3:00 |
| < back | ||
Homepage | ฉ 2011 TNBC Foundation, Inc. | Disclaimer